Kah-Leong Lim, PhD
Primary tabs
JAD profile
Affiliation(s):
Lee Kong Chian School of Medicine; Nanyang Technology University
ORCID URL:
Areas of Interest:
Parkinson's disease, Alzheimer's disease, vascular dementia
Biography & Research:
Kah-Leong Lim is Professor and Vice Dean (Research) and President’s Chair in Translational Neuroscience at the Lee Kong Chian School of Medicine, Nanyang Technological University (Singapore) and concurrently Research Director (Biomedical and Life Sciences) at NTU President’s office. He is also a Visiting Professor at the Department of Brain Sciences, Imperial College London (UK) and a Distinguished Visiting Academic at the National Neuroscience Institute (Singapore).
Dr. Lim obtained his Ph.D. from the Singapore Institute of Molecular & Cell Biology in 1999. Thereafter, he did his postdoctoral training firstly at the Department of Pathology in Harvard Medical School (2000-2001), and subsequently at the Department of Neurology in Johns Hopkins University School of Medicine (2001-2002) where he worked on the topic of Parkinson’s disease with Professor Ted Dawson. Dr Lim joined the National Neuroscience Institute of Singapore (NNI) as Head of Neurodegeneration Research Laboratory in July 2002 and became the Deputy Research Director of NNI before he left in 2018 to join the National University of Singapore (NUS) as the Head/Chair of the Department of Physiology at the Yong Loo Ling School of Medicine.
Dr Lim is a member of the National Neurosensory Task Force and Chair of its Subpanel on Ageing-related diseases and complications. He is also a member of the NMRC Grant Review Panel and an ad-hoc reviewer for several international grant agencies including Medical Research Council (UK) and Wellcome Trust (UK). Dr. Lim serves in the editorial board of several journals, including being an Associate editor of Neuromolecular Medicine, an academic editor for PLOS ONE, a guest editor for PLOS Genetics and a review editor for Frontiers in Cellular Neuroscience. To date, he has received several scientific awards for his research, including the Singapore Neuroscience Association Distinguished Neuroscientist Award and the (Singapore) President Science Award (Team) in 2018. Recently, he was also recognized as one of the “Overseas High-level Talents” under the Shanxi Province “Hundred Talents Program” in the People’s Republic of China. His research work focuses on unravelling the molecular basis of neurodegenerative diseases, with the view to develop novel therapeutics for these debilitating disorders. He has published more than 125 papers to date and his work has been cited > 22,000 times with a h-index of 53 (Google Scholar). In a ranking created by Stanford, Dr Lim was identified as one of the world’s top 2% most cited scientists .
1. https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3000918
